PLX.TA - Protalix BioTherapeutics, Inc.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
75.50
+0.50 (+0.67%)
At close: 5:24PM IDT
Stock chart is not supported by your current browser
Previous Close75.00
Open73.00
Bid75.60 x 128000
Ask73.00 x 209400
Day's Range73.00 - 76.00
52 Week Range70.00 - 276.70
Volume125,139
Avg. Volume208,778
Market Cap114.874M
Beta (3Y Monthly)2.70
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Associated Press

    Protalix: 1Q Earnings Snapshot

    On a per-share basis, the Carmiel, Israel-based company said it had a loss of 5 cents. The drug developer posted revenue of $10.4 million in the period. The company's shares closed at 44 cents. A year ...

  • Protalix (PLX) Reports Q3 Loss, Lags Revenue Estimates
    Zacks

    Protalix (PLX) Reports Q3 Loss, Lags Revenue Estimates

    Protalix (PLX) delivered earnings and revenue surprises of -150.00% and -91.71%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press

    Protalix: 3Q Earnings Snapshot

    On a per-share basis, the Carmiel, Israel-based company said it had a loss of 10 cents. The drug developer posted revenue of $663,000 in the period. The company's shares closed at 49 cents. A year ago, ...

  • Will Protalix (PLX) Report Negative Earnings Next Week? What You Should Know
    Zacks

    Will Protalix (PLX) Report Negative Earnings Next Week? What You Should Know

    Protalix (PLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.